CBS17 – North Carolina
by: Judith Retana
Posted: / Updated:
RALEIGH, N.C. (WNCN) – On Friday, the FDA will discuss Pfizer’s request for authorization for its booster.
In documents posted online, the FDA took note of conflicting data concerning boosters.
The agency said, “Some observational studies have suggested declining efficacy of COMIRNATY over time against symptomatic infection or against the Delta variant, while others have not.”